Tak Mao Chan
University of Hong Kong
401 Papers
3K Citations
Tak Mao Chan is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Lupus nephritis. The author has an hindex of 59, co-authored 388 publications. Previous affiliations of Tak Mao Chan include Pamela Youde Nethersole Eastern Hospital & Queen Mary Hospital.
Chat about Author
Papers
Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis
Carlos K. H. Wong,Julie Y. Chen,Samuel K. S. Fung,Maggie M Y Mok,Yuk Lun Cheng,Irene Kong,Wai Kei Lo,Sing Leung Lui,Tak Mao Chan,Cindy L. K. Lam +9 more
TL;DR: This study quantified the economic burden of ESRD patients, and assessed the annual healthcare and societal costs in the initial and second years of PD, hospital-based HD and nocturnal home HD in Hong Kong.
41
A possible role of HMGB1 in DNA demethylation in CD4+ T cells from patients with systemic lupus erythematosus.
Yaping Li,Chenghui Huang,Ming Zhao,Gongping Liang,Rong Xiao,Susan Yung,Tak Mao Chan,Qianjin Lu +7 more
TL;DR: The data demonstrate that HMGB1 binds to Gadd45a and may be involved in DNA demethylation in CD4+ T cells during lupus flare, and a significant, positive correlation was found betweenHMGB1 mRNA and SLEDAI for SLE patients.
Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.
Tak Mao Chan,Stephen K. N. Ho,Colin S.O. Tang,Kai Chung Tse,Man Fai Lam,Kar Neng Lai,Susan Yung +6 more
TL;DR: Pegylated interferon (PEG‐IFN) combined with ribavirin is recommended for the treatment of chronic hepatitis C virus (HCV) infection in patients without renal failure and the optimal treatment of hepatitis C in dialysis patients remains to be established.
41
Effect of rapamycin on renal ischemia-reperfusion injury in mice.
TL;DR: It is concluded that in this murine model of renal IRI, rapamycin treatment aggravates renal ischemia‐reperfusion injury during the first 3 days after the insult.
40
Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis:
K M Thong,Tak Mao Chan +1 more
TL;DR: Infection remains a serious complication during treatment of lupus nephritis, but the reported rates and outcomes varied markedly and mycophenolate as induction treatment was associated with lower infection risk than cyclophosphamide in non-Asians.
40